Vimentin loss inhibits DNA damage responses and promotes cancer cell survival.
- Open access
Vimentin loss impairs DNA repair and increases cancer cell survival under genotoxic stress, especially in glioblastoma cells, by disrupting nuclear mechanics.
- Why it matters: Understanding how vimentin influences genome maintenance is crucial because it affects tumor progression and therapy resistance, yet its mechanistic role remains unclear.
- What they did: The study used controlled cell compression, genetic, and pharmacological methods to show that vimentin promotes DNA repair by alleviating nuclear mechanical compression, with vimentin-negative cells exhibiting impaired damage sensing.
- The result: Suppressing DNA damage responses through vimentin loss enhances survival after treatments like temozolomide and radiation, revealing a mechanochemical axis that promotes therapy tolerance and genomic instability.